jump to search box

The future of drug safety [electronic resource] : promoting and protecting the health of the public / Committee on the Assessment of the US Drug Safety System, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies ; Alina Baciu, Kathleen Stratton, Sheila P. Burke, editors.

Availability

Online

Other libraries

Corporate Author:
Institute of Medicine (U.S.). Committee on the Assessment of the US Drug Safety System.
Language:
English.
Publication date:
2007
Imprint:
Washington, DC : National Academies Press, c2007.
Format:
  • Book
  • xii, 332 p. : ill.
Bibliography:
Includes bibliographical references and index.
Publisher's Summary:
In the wake of publicity and congressional attention to drug safety issues, the Food and Drug Administration (FDA) requested the Institute of Medicine assess the drug safety system. The committee reported that a lack of clear regulatory authority, chronic underfunding, organizational problems, and a scarcity of post-approval data about drugs' risks and benefits have hampered the FDA's ability to evaluate and address the safety of prescription drugs after they have reached the market. Noting that resources and therefore efforts to monitor medications' risk benefit profiles taper off after approval, "The Future of Drug Safety" offers a broad set of recommendations to ensure that consideration of safety extends from before product approval through the entire time the product is marketed and used.
(source: Nielsen Book Data)
Reproduction:
Electronic reproduction. Palo Alto, Calif. : ebrary, 2007. Available via World Wide Web. Access may be limited to ebrary affiliated libraries.
Contributor:
Baciu, Alina.
Stratton, Kathleen R.
Burke, Sheila P.
ebrary, Inc.
Subjects:
ISBN:
9786610844746
6610844747

powered by Blacklight
© Stanford University. Stanford, California 94305. (650) 725-1064. Terms of Use | Copyright Complaints | Opt Out of Analytics
jump to top